Clinical trial
Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation
NCT03492749 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation
- Lead sponsor
- Hospital Israelita Albert Einstein
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- August 31, 2020
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bone marrow disease